Non-alcoholic fatty liver disease CT: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Non alcoholic fatty liver disease}}
{{Non alcoholic fatty liver disease}}
'''Editor in Chief''': Elliot Tapper, M.D., Beth Israel Deaconess Medical Center, [[User:C Michael Gibson |C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com]
{{CMG}}; {{AE}} {{VKG}}
 
{{PleaseHelp}}


==Overview==
==Overview==

Revision as of 18:39, 15 December 2017

Non-Alcoholic Fatty Liver Disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Alcoholic Fatty Liver Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Non-alcoholic fatty liver disease CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-alcoholic fatty liver disease CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-alcoholic fatty liver disease CT

CDC on Non-alcoholic fatty liver disease CT

Non-alcoholic fatty liver disease CT in the news

Blogs on Non-alcoholic fatty liver disease CT

Directions to Hospitals Treating Non-alcoholic fatty liver disease

Risk calculators and risk factors for Non-alcoholic fatty liver disease CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

Overview

Imaging is often ordered in the workup of suspected NAFLD.Problematically, ultrasound of fatty liver reveals a hyperechoic echotexture - a so-called 'bright liver' - that can often be indistinguishable from fibrosis and generally cannot reliably delineate NAFLD from NASH. CT scan may be helpful in the diagnosis of complications of NAFLD, which include the structure of the liver. But using CT is limited because of the exposure to ionizing radiation. [1]Contrast enhanced CT has a sensitivity up to 84-87% and specificity of 75-86%.

CT scan

  • CT without contrast is an effective test for elavating liver strucutre and liver fat content.[2]
  • CT with contrast has less senstivity and specifcity and has additional risk of the contrast exposure

References

  1. "Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician".
  2. "Nonalcoholic Fatty Liver Disease: Diagnosis and Management - American Family Physician".

Template:WS Template:WH